Vienna, Austria

Juergen Mairhofer

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Engenes Biotech Gmbh. Active years: 2021-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Juergen Mairhofer: Innovator in Recombinant Biotechnology

Introduction

Juergen Mairhofer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of recombinant biotechnology, particularly in protein expression. His innovative approach has the potential to enhance the efficiency of protein production processes.

Latest Patents

Juergen Mairhofer holds a patent titled "Uncoupling growth and protein production." This invention focuses on methods to increase the expression level of a protein of interest in bacterial host cells during production. By expressing a phage protein that inhibits the growth of the bacterial host cell, Mairhofer's invention effectively decouples the growth of the host cell from the manufacturing of the protein. This process reduces metabolic burden, oxygen demand, metabolic heat development, and stress responses, thereby increasing the capacity of the host cell to produce the desired protein.

Career Highlights

Mairhofer is associated with Engenes Biotech GmbH, where he applies his expertise in biotechnology. His work is pivotal in advancing the field of protein expression and cell culture technology.

Collaborations

Some of his notable coworkers include Gerald Striedner and Reingard Grabherr, who contribute to the innovative environment at Engenes Biotech GmbH.

Conclusion

Juergen Mairhofer's contributions to recombinant biotechnology exemplify the impact of innovative thinking in the field of protein production. His patent demonstrates a significant advancement that could lead to more efficient biotechnological processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…